• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LI Hui, YANG Lingyun, ZHOU Jinpei, ZHANG Huibin. Synthesis and evaluation of oxazolidinone ether compounds as factor Xa inhibitors[J]. Journal of China Pharmaceutical University, 2013, 44(5): 385-389. DOI: 10.11665/j.issn.1000-5048.20130501
Citation: LI Hui, YANG Lingyun, ZHOU Jinpei, ZHANG Huibin. Synthesis and evaluation of oxazolidinone ether compounds as factor Xa inhibitors[J]. Journal of China Pharmaceutical University, 2013, 44(5): 385-389. DOI: 10.11665/j.issn.1000-5048.20130501

Synthesis and evaluation of oxazolidinone ether compounds as factor Xa inhibitors

More Information
  • According to the binding mode of rivaroxaban in complex with human factor Xa and the chemical structure of rivaroxaban, we have designed and synthesized the oxazolidinone ether compounds, which have not be reported in literatures. The structures of all the rivaroxaban derivatives synthesized were identified by IR, 1H NMR and MS. The anti-factor Xa activity of the synthesized compounds was tested. The results showed that all of the tested compounds exhibited some activity, yet were less potent than rivaroxaban.
  • Related Articles

    [1]HUO Zirui, PEI Jieyu, ZHAN Fangyi, XIE Shaowen, XU Jinyi, XU Shengtao. Research advances in small-molecule hydrophobic tagging protein degraders[J]. Journal of China Pharmaceutical University, 2025, 56(2): 252-263. DOI: 10.11665/j.issn.1000-5048.2024031301
    [2]YAO Chunlu, ZHANG Weijie, ZHANG Yunlong, DENG Zhaoxia, WANG Mengling, ZHANG Zuoling, WANG Chen, SONG Qinxin, ZOU Bingjie. Progress of single-cell protein imaging methods[J]. Journal of China Pharmaceutical University, 2024, 55(2): 147-157. DOI: 10.11665/j.issn.1000-5048.2024010205
    [3]CAO Jin, CHEN Hao, ZHANG Jing, ZHU Jianwei, CHEN Junsheng. Expression and purification of soluble recombinant antibody fragment and immunotoxin in Escherichia coli using Npu DnaE C-cleavage mutant[J]. Journal of China Pharmaceutical University, 2020, 51(2): 213-222. DOI: 10.11665/j.issn.1000-5048.20200213
    [4]TAO Linlin, HUO Meirong, XU Wei. Advances in the research of protein nanocarrier materials[J]. Journal of China Pharmaceutical University, 2020, 51(2): 121-129. DOI: 10.11665/j.issn.1000-5048.20200201
    [5]LI Qingmei, WANG Shuzhen. Advances of relationship between protein Neddylation and cancer[J]. Journal of China Pharmaceutical University, 2018, 49(3): 272-278. DOI: 10.11665/j.issn.1000-5048.20180303
    [6]ZHANG Xinran, LI Bo, DI Bin. Advances in racemization of protein amino acid[J]. Journal of China Pharmaceutical University, 2017, 48(4): 407-415. DOI: 10.11665/j.issn.1000-5048.20170404
    [7]Wu Mengqiu, WU Mengqiu, LU Gaoyuan, SHAO Chang, WANG Dandan, SUN Di, HAO Haiping, WANG Guangji. Mass spectrometry-based protein quantification and its application in pharmacokinetic research[J]. Journal of China Pharmaceutical University, 2015, 46(2): 129-140. DOI: 10.11665/j.issn.1000-5048.20150201
    [8]Progress in Protein Microarray and Its Applications[J]. Journal of China Pharmaceutical University, 2001, (5): 11-14.
    [9]IMPROVEMENT OF PROTEIN DETERMINATION WITH COOMASSIE BRILLIANT BLUE G-250 DYE[J]. Journal of China Pharmaceutical University, 1987, (2): 133-136.
    [10]Chen Qionghua. The Nutrition Value of Fermented Soy Bean Curd Protein[J]. Journal of China Pharmaceutical University, 1979, (2): 7-12.

Catalog

    Article views (1342) PDF downloads (2273) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return